Polyethylene glycol-based protein nanocapsules for functional delivery of a differentiation transcription factor

Biomaterials

Volumn 33, Issue 21, 2012, Pages 5459-5467

  Biswas, Anuradha ^a   Liu, Ying ^b   Liu, Tianfei ^a   Fan, Guoping ^b   Tang, Yi ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Degradable; Differentiation; Intracellular; Nanocapsule; Protein; Transcription factor

Indexed keywords

CARGO DELIVERY; CELL FATES; CELLULAR DIFFERENTIATION; CELLULAR FUNCTION; CROSS-LINKERS; CROSSLINKER RATIO; DEGRADABLE; GENE TRANSCRIPTIONS; IMMUNOSTAINING; INTRACELLULAR; INTRACELLULAR LEVELS; MEMBRANE TRANSDUCTION; MYOBLAST CELLS; MYOBLASTS; MYOGENIC TRANSCRIPTION; MYOTUBES; PLASMID TRANSFECTION; PRIMARY CELLS; PROTEASE TREATMENT; RELEASE KINETICS; REPORTER ASSAY; TARGET CELLS; THERAPEUTIC USE; THERAPEUTIC VALUES;

BIOCOMPATIBILITY; CELL CULTURE; CONFOCAL MICROSCOPY; DIFFERENTIATION (CALCULUS); ETHYLENE; FUNCTIONAL POLYMERS; GENES; GLYCOLS; MONOMERS; POLYETHYLENE GLYCOLS; PROTEINS; TRANSCRIPTION; TRANSCRIPTION FACTORS;

NANOCAPSULES;

MACROGOL; MYOD PROTEIN; MYOGENIN; NANOCAPSULE;

ARTICLE; BIOCOMPATIBILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; KINETICS; MYOBLAST; MYOTUBE; PLASMID; PRIORITY JOURNAL;

ANIMALS; CELL DIFFERENTIATION; CELL LINE; CELL NUCLEUS; DRUG DELIVERY SYSTEMS; FURIN; HUMANS; MICE; MUSCLE FIBERS, SKELETAL; MYOBLASTS; MYOD PROTEIN; NANOCAPSULES; OXIDATION-REDUCTION; PEPTIDE HYDROLASES; POLYETHYLENE GLYCOLS;

EID: 84860917830     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.04.012     Document Type: Article

References (60)

1. Latchman D.S. Transcription factors: an overview. Int J Biochem Cell Biol 1997, 29:1305-1312.
2. Farnham P.J. Insights from genomic profiling of transcription factors. Nat Rev Genet 2009, 10:605-616.
3. Lobe C.G. Transcription factors and mammalian development. Curr Top Dev Biol 1992, 27:351-383.
4. Vaquerizas J.M., Kummerfeld S.K., Teichmann S.A., Luscombe N.M. A census of human transcription factors: function, expression and evolution. Nat Rev Genet 2009, 10:252-263.
5. Blelloch R. Regenerative medicine - short cut to cell replacement. Nature 2008, 455:604-605.
6. Jopling C., Boue S., Belmonte J.C.I. Dedifferentiation, transdifferentiation and reprogramming: three routes to regeneration. Nat Rev Mol Cell Biol 2011, 12:79-89.
7. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
8. Wernig M., Meissner A., Foreman R., Brambrink T., Ku M.C., Hochedlinger K., et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 2007, 448:318-323U2.
9. Parkinson D.B., Bhaskaran A., Arthur-Farraj P., Noon L.A., Woodhoo A., Lloyd A.C., et al. c-Jun is a negative regulator of myelination. J Cell Biol 2008, 181:625-637.
10. Crocker S.J., Lamba W.R., Smith P.D., Callaghan S.M., Slack R.S., Anisman H., et al. c-Jun mediates axotomy-induced dopamine neuron death in vivo. Proc Natl Acad Sci U S A 2001, 98:13385-13390.
11. Xie H.F., Ye M., Feng R., Graf T. Stepwise reprogramming of B cells into macrophages. Cell 2004, 117:663-676.
12. Ferber S., Ber I., Shternhall K., Perl S., Ohanuna Z., Goldberg I., et al. Functional, persistent, and extended liver to pancreas transdifferentiation. J Biol Chem 2003, 278:31950-31957.
13. Hori S., Nomura T., Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003, 299:1057-1061.
14. Vierbuchen T., Ostermeier A., Pang Z.P., Kokubu Y., Sudhof T.C., Wernig M. Direct conversion of fibroblasts to functional neurons by defined factors. Nature 2010, 463. 1035-U50.
15. Bian J., Popovic Z.B., Benejam C., Kiedrowski M., Rodriguez L.L., Penn M.S. Effect of cell-based intercellular delivery of transcription factor GATA4 on ischemic cardiomyopathy. Circ Res 2007, 100:1626-1633.
16. Zaret K.S., Grompe M. Generation and regeneration of cells of the liver and pancreas. Science 2008, 322:1490-1494.
17. Yamanaka S. A fresh look at iPS cells. Cell 2009, 137:13-17.
18. Hacein-Bey-Abina S., Von Kalle C., Schmidt M., McCcormack M.P., Wulffraat N., Leboulch P., et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 2003, 302:415-419.
19. Okita K., Ichisaka T., Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 2007, 448. 313-3U1.
20. Stadtfeld M., Nagaya M., Utikal J., Weir G., Hochedlinger K. Induced pluripotent stem cells generated without viral integration. Science 2008, 322:945-949.
21. Okita K., Nakagawa M., Hong H.J., Ichisaka T., Yamanaka S. Generation of mouse induced pluripotent stem cells without viral vectors. Science 2008, 322:949-953.
22. Kaji K., Norrby K., Paca A., Mileikovsky M., Mohseni P., Woltjen K. Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature 2009, 458. 771-U112.
23. Woltjen K., Michael I.P., Mohseni P., Desai R., Mileikovsky M., Hamalainen R., et al. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 2009, 458. 766-U106.
24. Zhou H.Y., Wu S.L., Joo J.Y., Zhu S.Y., Han D.W., Lin T.X., et al. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell. 2009, 4:381-384.
25. Kim D., Kim C.H., Moon J.I., Chung Y.G., Chang M.Y., Han B.S., et al. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell. 2009, 4:472-476.
26. Murriel C., Dowdy S. Influence of protein transduction domains on intracellular delivery of macromolecules. Expert Opin Drug Deliv 2006, 3:739-746.
27. Gu Z., Biswas A., Zhao M.X., Tang Y. Tailoring nanocarriers for intracellular protein delivery. Chem Soc Rev 2011, 40:3638-3655.
28. Latchman D.S. Transcription-factor mutations and disease. N Engl J Med 1996, 334:28-33.
29. Debs R.J., Freedman L.P., Edmunds S., Gaensler K.L., Duzgunes N., Yamamoto K.R. Regulation of gene-expression in vivo by liposome-mediated delivery of a purified transcription factor. J Biol Chem 1990, 265:10189-10192.
30. Dyson H.J., Wright P.E. Intrinsically unstructured proteins and their functions. Nat Rev Mol Cell Biol 2005, 6:197-208.
31. Gu Z., Yan M., Hu B., Joo K.I., Biswas A., Huang Y., et al. Protein nanocapsule weaved with enzymatically degradable polymeric network. Nano Lett 2009, 9:4533-4538.
32. Biswas A., Joo K.I., Liu J., Zhao M.X., Fan G.P., Wang P., et al. Endoprotease-mediated intracellular protein delivery using nanocapsules. ACS Nano 2011, 5:1385-1394.
33. Zhao M.X., Biswas A., Hu B.L., Joo K.I., Wang P., Gu Z., et al. Redox-responsive nanocapsules for intracellular protein delivery. Biomaterials 2011, 32:5223-5230.
34. Thomas G. Furin at the cutting edge: from protein traffic to embryogenesis and disease. Nat Rev Mol Cell Biol 2002, 3:753-766.
35. Meister A., Tate S.S. Glutathione and related gamma-glutamyl compounds-biosynthesis and utilization. Ann Rev Biochem 1976, 45:559-604.
36. Knop K., Hoogenboom R., Fischer D., Schubert U.S. Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives. Angew Chem Int Ed Engl 2010, 49:6288-6308.
37. Karakoti A.S., Das S., Thevuthasan S., Seal S. PEGylated inorganic nanoparticles. Angew Chem Int Ed Engl 2011, 50:1980-1994.
38. Govender T., Riley T., Ehtezazi T., Garnett M.C., Stolnik S., Illum L., et al. Defining the drug incorporation properties of PLA-PEG nanoparticles. Int J Pharm 2000, 199:95-110.
39. Webster R., Didier E., Harris P., Siegel N., Stadler J., Tilbury L., et al. PEGylated proteins: evaluation of their safety in the absence of definitive metabolism studies. Drug Metab Dispos 2007, 35:9-16.
40. Gu Z., Biswas A., Joo K.I., Hu B., Wang P., Tang Y. Probing protease activity by single-fluorescent-protein nanocapsules. Chem Commun (Camb) 2010, 4:6467-6469.
41. Gratton S.E., Ropp P.A., Pohlhaus P.D., Luft J.C., Madden V.J., Napier M.E., et al. The effect of particle design on cellular internalization pathways. Proc Natl Acad Sci U S A 2008, 105:11613-11618.
42. Ledent V., Vervoort M. The basic helix-loop-helix protein family: comparative genomics and phylogenetic analysis. Genome Res 2001, 11:754-770.
43. Weintraub H., Davis R., Tapscott S., Thayer M., Krause M., Benezra R., et al. The myoD gene family: nodal point during specification of the muscle cell lineage. Science 1991, 251:761-766.
44. Tapscott S.J. The circuitry of a master switch: Myod and the regulation of skeletal muscle gene transcription. Development 2005, 132:2685-2695.
45. Starovasnik M.A., Blackwell T.K., Laue T.M., Weintraub H., Klevit R.E. Folding topology of the disulfide-bonded dimeric DNA-binding domain of the myogenic determination factor MyoD. Biochemistry 1992, 31:9891-9903.
46. Anthonycahill S.J., Benfield P.A., Fairman R., Wasserman Z.R., Brenner S.L., Stafford W.F., et al. Molecular characterization of helix-loop-helix peptides. Science 1992, 255:979-983.
47. Yaffe D., Saxel O. Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature 1977, 270:725-727.
48. Noda T., Fujino T., Mie M., Kobatake E. Transduction of MyoD protein into myoblasts induces myogenic differentiation without addition of protein transduction domain. Biochem Biophys Res Commun 2009, 382:473-477.
49. Lassar A.B., Buskin J.N., Lockshon D., Davis R.L., Apone S., Hauschka S.D., et al. MyoD is a sequence-specific DNA binding protein requiring a region of myc homology to bind to the muscle creatine kinase enhancer. Cell 1989, 58:823-831.
50. Seward D.J., Haney J.C., Rudnicki M.A., Swoap S.J. bHLH transcription factor MyoD affects myosin heavy chain expression pattern in a muscle-specific fashion. Am J Physiol Cell Physiol 2001, 280:C408-C413.
51. Muroya S., Nakajima I., Chikuni K. Related expression of MyoD and Myf5 with myosin heavy chain isoform types in bovine adult skeletal muscles. Zoolog Sci 2002, 19:755-761.
52. Charge S.B., Rudnicki M.A. Cellular and molecular regulation of muscle regeneration. Physiol Rev 2004, 84:209-238.
53. Armand A.S., Bourajjaj M., Martinez-Martinez S., el Azzouzi H., da Costa Martins P.A., Hatzis P., et al. Cooperative synergy between NFAT and MyoD regulates myogenin expression and myogenesis. J Biol Chem 2008, 283:29004-29010.
54. Hamamori Y., Wu H.Y., Sartorelli V., Kedes L. The basic domain of myogenic basic helix-loop-helix (bHLH) proteins is the novel target for direct inhibition by another bHLH protein. Twist Mol Cell Biol 1997, 17:6563-6573.
55. Shklover J., Etzioni S., Weisman-Shomer P., Yafe A., Bengal E., Fry M. MyoD uses overlapping but distinct elements to bind E-box and tetraplex structures of regulatory sequences of muscle-specific genes. Nucleic Acids Res 2007, 35:7087-7095.
56. Bengal E., Flores O., Rangarajan P.N., Chen A., Weintraub H., Verma I.M. Positive control mutations in the MyoD basic region fail to show cooperative DNA binding and transcriptional activation in vitro. Proc Natl Acad Sci U S A 1994, 91:6221-6225.
57. Ishibashi J., Perry R.L., Asakura A., Rudnicki M.A. MyoD induces myogenic differentiation through cooperation of its NH2- and COOH-terminal regions. J Cell Biol 2005, 171:471-482.
58. Etzioni S., Yafe A., Khateb S., Weisman-Shomer P., Bengal E., Fry M. Homodimeric MyoD preferentially binds tetraplex structures of regulatory sequences of muscle-specific genes. J Biol Chem 2005, 280:26805-26812.
59. Lluis F., Ballestar E., Suelves M., Esteller M., Munoz-Canoves P. E47 phosphorylation by p38 MAPK promotes MyoD/E47 association and muscle-specific gene transcription. EMBO J 2005, 24:974-984.
60. Ebeling W., Hennrich N., Klockow M., Metz H., Orth H.D., Lang H. Proteinase K from Tritirachium album limber. Eur J Biochem 1974, 47:91-97.